Latest Pravachol news
Pravastatin Does Not Improve Survival in Small-Cell Lung Cancer
posted March 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with small-cell lung cancer, addition of pravastatin to standard chemotherapy does not improve survival, according to a study published online Feb. 27 in the Journal of Clinical Oncology.
Gene Mutation Identified That Increases Lung Cancer Risk 
Relapse Rare After Appendiceal Adenocarcinoma Resection 
Cancer Drug Shortages Persist at All Cancer Centers 
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML Related Articles
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Early Survivorship Care Linked to Improved Outcomes in Head, Neck Cancer .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy Monthly Specialist Briefings
Stay Connected
